15th Annual Congress on Controversies in Ophthalmology (COPHy 2024)

Find Out More

diabetic macular edema (DME)

FDA approves Vabysmo for treatment of wet AMD, DME

The FDA has approved Vabysmo for the treatment of wet age-related macular degeneration and diabetic macular edema, according to a press release from Genentech. Vabysmo (faricimab-svoa) is an injectable eye medicine…

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.